Insulin resistance doesn’t show up on most routine blood panels, which is why many people have it for years without knowing. Standard checkups typically measure fasting blood sugar or HbA1c, both of which can remain perfectly normal while your body is already pumping out two or three times the normal amount of insulin to keep glucose in check. Testing specifically for insulin resistance requires looking beyond glucose alone.
Several reliable methods exist, ranging from simple blood tests your doctor can order to at-home options you can purchase yourself. Here’s what each test actually measures, what the numbers mean, and which approach makes the most sense depending on your situation.
Why Standard Blood Sugar Tests Miss It
Most annual physicals include a fasting glucose test or an HbA1c reading. Both measure how well your body controls blood sugar, but neither tells you how hard your body is working to maintain that control. In the early stages of insulin resistance, your pancreas compensates by producing extra insulin, keeping glucose levels in the normal range. Your blood sugar looks fine on paper while your insulin levels are quietly climbing.
Research published in Diabetes Care found that considering insulin resistance alongside HbA1c identified people at high risk for type 2 diabetes even when their HbA1c appeared completely normal. This is the core problem: glucose-based tests catch the downstream damage, not the upstream cause. By the time fasting glucose or HbA1c starts rising, insulin resistance has often been building for years.
Fasting Insulin: The Simplest Direct Test
A fasting insulin test measures the amount of insulin circulating in your blood after an overnight fast. It’s a straightforward blood draw, and it’s the most direct way to see whether your body is overproducing insulin. Normal fasting insulin generally falls below 10 to 12 µIU/mL, though optimal levels are often cited as under 5 to 7 µIU/mL. Higher numbers suggest your pancreas is working overtime to keep blood sugar down.
This test is inexpensive and widely available, but it has a limitation: it captures a single snapshot. Insulin levels fluctuate throughout the day, so one reading doesn’t tell the whole story. Still, a clearly elevated fasting insulin level is one of the earliest and most actionable signs of insulin resistance, often showing up years before glucose abnormalities appear.
HOMA-IR: Combining Insulin and Glucose
HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) is the most commonly used calculation for estimating insulin resistance from a single fasting blood draw. The formula multiplies your fasting insulin (in µIU/mL) by your fasting glucose (in mmol/L), then divides by 22.5. Most labs can calculate this for you, or you can do it yourself if you have both numbers.
A HOMA-IR score below 1.0 is considered optimal. Scores between 1.0 and about 2.0 fall in a gray zone. A score above 2.0 to 2.6 is widely used as the threshold for insulin resistance, with cutoff values typically falling between 2.0 and 2.6 depending on the population being studied. The higher the number, the more resistant your cells are to insulin’s effects. Because it combines two measurements, HOMA-IR gives a more complete picture than either fasting glucose or fasting insulin alone.
The Oral Glucose Tolerance Test
An oral glucose tolerance test (OGTT) goes further by measuring how your body handles a sugar load in real time. You drink a solution containing 75 grams of glucose, and your blood is drawn at intervals over the next two hours. The standard benchmarks at the two-hour mark are:
- Normal: below 140 mg/dL
- Prediabetes: 140 to 199 mg/dL
- Diabetes: 200 mg/dL or higher
The OGTT is better at catching problems that a fasting test misses, because some people have normal fasting numbers but can’t process a large glucose load efficiently. If your doctor orders this test with insulin measurements at each time point (not just glucose), it becomes even more revealing. Watching how high insulin spikes and how slowly it comes back down shows exactly how hard your body is fighting to clear sugar from the bloodstream.
Your Triglyceride-to-HDL Ratio
One of the easiest ways to screen for insulin resistance is a number you may already have from a standard cholesterol panel: your triglyceride-to-HDL ratio. You simply divide your triglyceride level by your HDL cholesterol level (both in mg/dL).
For most populations, a ratio above 2.5 for women and above 2.8 for men suggests insulin resistance. For people of African descent, the thresholds are lower: above 1.5 for women and above 2.0 for men. These ethnicity-specific differences matter because triglyceride metabolism varies between populations, making a single universal cutoff unreliable. A large review of studies confirmed the triglyceride-to-HDL ratio has strong predictive power across different body weights and ages, in both adults and children.
This ratio won’t replace a direct insulin measurement, but it’s a useful and essentially free screening tool if you already have recent lipid panel results sitting in your patient portal.
The LP-IR Score
The Lipoprotein Insulin Resistance score (LP-IR) is a newer test that estimates insulin resistance by analyzing the sizes and concentrations of cholesterol particles in your blood. Rather than measuring insulin directly, it looks at patterns in how your body packages and transports fat, which shifts in characteristic ways as insulin resistance develops. The score runs from 0 (most insulin sensitive) to 100 (most insulin resistant).
The LP-IR score performs comparably to HOMA-IR and other established indices in predicting insulin resistance. Its advantage is that it doesn’t require fasting insulin to be measured separately, and it pulls from a specialized lipid panel. Labcorp offers this test through its direct-to-consumer platform, performed at a certified clinical lab from a standard blood draw. It’s a reasonable option if you want a more detailed metabolic picture without needing a doctor’s order, though it costs more than a basic fasting insulin test.
Physical Signs Worth Noticing
Your body sometimes advertises insulin resistance before any blood test catches it. The most recognizable sign is acanthosis nigricans: dark, velvety patches of skin that appear in body folds, especially the neck, armpits, and groin. These patches often develop alongside small skin tags in the same areas. The darkening happens because excess insulin stimulates skin cell growth, and it’s common enough that clinicians use it as a visual screening tool, particularly in younger people.
Other physical patterns that correlate with insulin resistance include weight concentrated around the midsection (a waist circumference above 35 inches for women or 40 inches for men), persistent difficulty losing weight despite consistent effort, and fatigue or brain fog after carbohydrate-heavy meals. None of these are diagnostic on their own, but a cluster of them is a strong signal that formal testing is worthwhile.
Which Test to Start With
If you’re trying to get a clear answer with minimal cost and hassle, the best starting point is a fasting insulin test combined with a fasting glucose test. Together, these give you a fasting insulin level and everything you need to calculate HOMA-IR. Most doctors will order these if you ask, and the total cost is typically low even without insurance.
If you already have a recent lipid panel, check your triglyceride-to-HDL ratio first. A high ratio gives you immediate grounds to pursue more specific testing. If your doctor is resistant to ordering a fasting insulin test (some still don’t consider it standard practice), direct-to-consumer options through companies like Labcorp let you order bloodwork yourself and walk into a lab without a prescription.
For the most thorough assessment, an OGTT with insulin levels measured at each time point reveals how your body responds dynamically to sugar, not just at rest. This is particularly useful if your fasting numbers look borderline but you suspect something is off. The combination of a fasting baseline and a dynamic challenge test leaves very little room for insulin resistance to hide.